Dr. Lalchandani Labs Ltd.BSE: DLCL

Dr. Lalchandani Labs Ltd. Press Release Sep 03 2025

· Issued by Dr. Lalchandani Labs Ltd.

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Arjan Lalchandani

View Attachment